| Patents for C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media (9,992) |
|---|
| 06/24/2004 | WO2004053093A2 Method of inhibiting neural transmission mediated by serotonin-2a and enhancing sensorimotor gating |
| 06/24/2004 | WO2004053090A2 Method and system for utilizing somatic cell nuclear transfer embryos as cell donors for additional nuclear transfer |
| 06/24/2004 | WO2004053076A2 Methods for rapid detection and identification of bioagents for environmental and product testing |
| 06/24/2004 | WO2004053074A2 Outcome prediction and risk classification in childhood leukemia |
| 06/24/2004 | WO2003027264A3 Coisogenic eukaryotic cell collections |
| 06/24/2004 | US20040123334 Methods of treating neurodegenerative diseases |
| 06/24/2004 | US20040121367 Primers and primer sets for use in methods to detect the presence of Acidovorax avenae subsp. citrulli |
| 06/24/2004 | US20040121314 using primers which hybridize to conserved sequence regions of nucleic acids derived from a bioagent and which bracket variable sequence regions that uniquely identify the bioagent, resulting in a base composition signature (BCS) |
| 06/24/2004 | CA2509465A1 Method and system for utilizing somatic cell nuclear transfer embryos as cell donors for additional nuclear transfer |
| 06/24/2004 | CA2508359A1 Direct snp detection with unamplified dna |
| 06/23/2004 | EP1430137A2 Porcine adenovirus e1 and e4 regions |
| 06/23/2004 | CN1154725C Human bikunin |
| 06/22/2004 | US6753458 Process for obtaining transgenic leguminous plants (leguminosae) containing exogenous DNA |
| 06/17/2004 | WO2004050897A2 Methods for preparing antigen masked red blood cells having reduced hemolysis by sera |
| 06/17/2004 | WO2004050848A2 Methods for antigen masking of red blood cells resulting in reduced hemolysis |
| 06/17/2004 | WO2004050840A2 Integration of gene expression data and non-gene data |
| 06/17/2004 | WO2004050839A2 Fragmentation-based methods and systems for sequence variation detection and discovery |
| 06/17/2004 | WO2004050828A2 Nucleic acid corresponding protein entitled 24p4c12 useful in treatment and detection of cancer |
| 06/17/2004 | WO2004050029A2 Novel activated polyethylene glycol compounds |
| 06/17/2004 | WO2004049914A2 Methods for reacting an antigen masking compound with red blood cells with high efficiency |
| 06/17/2004 | WO2004016742A3 α(1,3)-GALACTOSYLTRANSFERASE NULL CELLS, METHODS OF SELECTING AND α(1,3)-GALACTOSYLTRANSFERASE NULL SWINE PRODUCED THEREFROM |
| 06/17/2004 | WO2004013282A3 Bis (amino acid) molecular scaffolds |
| 06/17/2004 | WO2003068907A3 Method for the generation of proteins with new enzymatic function |
| 06/17/2004 | WO2003058199A3 Arrays of microparticles and methods of preparation thereof |
| 06/17/2004 | WO2003032810A3 Treatment and diagnosis of insulin resistant states |
| 06/17/2004 | US20040116654 Isolated polypeptides; genetic engineering; quantitative analysis |
| 06/17/2004 | US20040115813 Using differential colorimetric analysis to determine heterogeneity of tumors; diagnosis and characterization of poliferation products |
| 06/17/2004 | US20040115128 Targeting endothelium for tissue-specific delivery of agents |
| 06/17/2004 | CA2507189A1 Fragmentation-based methods and systems for sequence variation detection and discovery |
| 06/17/2004 | CA2503346A1 Nucleic acid and corresponding protein entitled 24p4c12 useful in treatment and detection of cancer |
| 06/16/2004 | EP1427830A2 Bv8 NUCLEIC ACIDS AND POLYPEPTIDES WITH MITOGENIC ACTIVITY |
| 06/16/2004 | CN1153780C Protein with thrombopoiesis substance activity |
| 06/16/2004 | CN1153510C Vaccination against coccidiosis in ovum |
| 06/10/2004 | WO2004048548A2 Methods for identifying risk of breast cancer and treatments thereof |
| 06/10/2004 | WO2004048546A2 Methods for identifying risk of breast cancer and treatments thereof |
| 06/10/2004 | WO2004048541A2 Cct6s as modifiers of the rb pathway and methods of use |
| 06/10/2004 | WO2004048536A2 Rhebs as modifiers of the rb pathway and methods of use |
| 06/10/2004 | WO2004048532A2 Inferring gene regulatory networks from time-ordered gene expression data using differential equations |
| 06/10/2004 | WO2004048530A2 Compositions and methods for the reversible capture of biomolecules |
| 06/10/2004 | WO2004048524A2 Modulation of stat2 expression |
| 06/10/2004 | WO2004048522A2 Modulation of huntingtin interacting protein 2 expression |
| 06/10/2004 | WO2004031366A3 Manufacturing method and readout system for biopolymer arrays |
| 06/10/2004 | WO2004000995A3 Methods, probes, and accessory molecules for detecting single nucleotide polymorphisms |
| 06/10/2004 | WO2003064626A3 Double-stranded oligonucleotides |
| 06/10/2004 | WO2003048318A3 Methods for the identification of genetic features |
| 06/10/2004 | US20040110806 Dipeptide derivatives |
| 06/10/2004 | US20040110712 Methods for treating patients and identifying therapeutics |
| 06/10/2004 | US20040110167 Rapid and accurate detection of amplified and nonamplified nucleic acid sequences while being simple, economical and ready to use; self-contained; device contains all reagents necessary for the assay in an anhydrous format |
| 06/10/2004 | CA2506686A1 Cct6s as modifiers of the rb pathway and methods of use |
| 06/10/2004 | CA2504856A1 Inferring gene regulatory networks from time-ordered gene expression data using differential equations |
| 06/09/2004 | EP1019516B1 A process for obtaining transgenic leguminous plants (leguminosae) containing exogenous dna |
| 06/09/2004 | CN1502697A Alzhimer's disease secretase |
| 06/09/2004 | CN1502696A Alzheimer's disease secretase |
| 06/09/2004 | CN1502692A Alzheimer's disease secretase |
| 06/09/2004 | CN1152962C Antiangiogenic peptides derived from plasminogen, its coded polynucleotide and method of inhibiting vascularization |
| 06/09/2004 | CN1152960C ICAM-4 materials and methods |
| 06/08/2004 | US6747060 Non-natural galanin receptor ligands |
| 06/03/2004 | WO2004046379A1 Nucleic acid probes and broad-range primers from regions in topoisomerase genes, and methods in which they are used |
| 06/03/2004 | WO2004046344A2 Polynucleotide sequence detection assays |
| 06/03/2004 | WO2004046343A2 Polynucleotide sequence detection assays and analysis |
| 06/03/2004 | WO2004046335A2 A method for cloning of a rare, specifically mutated cell |
| 06/03/2004 | WO2004046318A2 Improved clonal cell lines derived from bti-tn-5b1-4 |
| 06/03/2004 | WO2004046313A2 Methods and compositions for determining methylation profiles |
| 06/03/2004 | WO2004046310A2 Novel mouse polypeptides encoded by polynucleotides and methods of their use |
| 06/03/2004 | WO2004046307A2 Scanning of biological samples |
| 06/03/2004 | WO2004001015A3 Method for sequencing nucleic acids |
| 06/03/2004 | US20040107453 Multipotent adult stem cells, sources thereof, methods of obtaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof |
| 06/03/2004 | CA2506058A1 Nucleic acid probes and broad-range primers from regions in topoisomerase genes, and methods in which they are used |
| 06/03/2004 | CA2505687A1 Polynucleotide sequence detection assays and analysis |
| 06/03/2004 | CA2489360A1 Methods and compositions for determining methylation profiles |
| 06/02/2004 | EP1423431A2 Antibodies to vla-1 |
| 06/01/2004 | US6743624 Process for continuous purification and concentration of leukocytes from blood |
| 05/27/2004 | WO2004044178A2 Methods and compositions for diagnosing dysplasia |
| 05/27/2004 | WO2004044177A2 Expression profiling based on histocultures |
| 05/27/2004 | WO2004044164A2 Method for identifying risk of melanoma and treatments thereof |
| 05/27/2004 | WO2004044163A2 Methods for identifying risk of melanoma and treatments thereof |
| 05/27/2004 | WO2004044150A2 Systems for gene targeting and producing stable genomic transgen e insertions |
| 05/27/2004 | WO2004044145A2 Compositions and methods for enhancing disease resistance in fish |
| 05/27/2004 | WO2004044141A2 Conjugated oligomeric compounds and their use in gene modulation |
| 05/27/2004 | WO2004044140A2 2’-substituted oligomeric compounds and compositions for use in gene modulations |
| 05/27/2004 | WO2004044138A2 Chimeric oligomeric compounds and their use in gene modulation |
| 05/27/2004 | WO2004044137A2 Modified oligomeric compounds and compositions for use in gene modulation |
| 05/27/2004 | WO2004044135A2 Structural motifs and oligomeric compounds and their use in gene modulation |
| 05/27/2004 | WO2004044134A2 Phosphorous-linked oligomeric compounds and their use in gene modulation |
| 05/27/2004 | WO2004044131A2 Cross-linked oligomeric compounds and their use in gene modulation |
| 05/27/2004 | WO2004044128A2 An associative analysis of gene expression array data |
| 05/27/2004 | WO2004044123A2 Bioinformatically detectable group of novel regulatory genes and uses thereof |
| 05/27/2004 | WO2004044122A2 Parallel or antiparallel, homologous or complementary binding of nucleic acids or analogues thereof to form duplex, triplex or quadruplex complexes |
| 05/27/2004 | WO2004043978A2 2'-methoxy substituted oligomeric compounds and compositions for use in gene modulations |
| 05/27/2004 | WO2004043977A2 2’-fluoro substituted oligomeric compounds and compositions for use in gene modulations |
| 05/27/2004 | WO2004043232A2 Methods for identifying risk of melanoma and treatments thereof |
| 05/27/2004 | WO2004018626A3 Abasic site endonuclease assay |
| 05/27/2004 | US20040102394 Using compositions comprising oligonucleotides targeted to nucleic acid encoding huntingtin interacting protein 2; for diagnosis and treatment of disease associated with expression of huntingtin interacting protein 2 |
| 05/27/2004 | US20040101947 A cationic or nonionic surfactant having a hydrophobic-lipophilic balance value from about 11 to 16 and a cell membrane altering compound, used for extracting a protein or peptide from target cell |
| 05/27/2004 | US20040101894 Microarrays having multiple oligonucleotides in single array features |
| 05/27/2004 | US20040101893 Abasic site endonuclease assay |
| 05/27/2004 | US20040101876 Methods and systems for annotating biomolecular sequences |
| 05/27/2004 | US20040101853 Modulation of STAT2 expression |
| 05/27/2004 | CA2505895A1 Expression profiling based on histocultures |
| 05/27/2004 | CA2505090A1 Conjugated oligomeric compounds and their use in gene modulation |